Back to Investors
GG

G.K. Goh Ventures

Venture Capital

G. K. Goh Ventures focuses on early-stage, science-based ventures including deep tech and medical spinouts.

Portfolio

3

companies


Portfolio companies

Kneu Health

Kneu Health

A precision neurology platform for tracking Parkinson and dementia via smartphones.

ST

Sention Technologies

Sention Technologies provides proprietary ultrasonic scanning and software for battery diagnostics.

Navenio

Navenio

Navenio provides indoor location technology and task allocation software to improve healthcare workflow efficiency.


Recent investments

Seed
£4.2M

The round was co-led by Oxford Science Enterprises and Cedars-Sinai to accelerate US expansion.

"We’ve spent the last two years proving that remote monitoring can transform neurological care. Clinicians are getting clearer insight without added workload, patients no longer face months of uncertainty between visits, and gain confidence that changes will be recognized rather than missed."
— Caroline Cake, co-founder and CEO
Seed
£3.7M

The seed round was led by Twin Path Ventures to commercialise ultrasonic battery diagnostics.

"This funding represents a significant milestone for Sention as we continue to innovate at the forefront of battery diagnostics. We are grateful to our investors for supporting our mission to enable the electrochemical power revolution by enhancing the performance, quality, and safety of batteries."
— Dan Brett, CEO
Series A
£5.0M

The funding round was led by Oxford Science Enterprises to support growth in the US and UK markets.

"We invest in companies with the potential to become leaders in their field, and that is why we’re proud to back the incredible team at Navenio on their latest fundraise. Navenio is revolutionising the way we create more efficient healthcare workplaces, through its proven technology powered platform for indoor mapping, and we are excited to continue supporting the team on the next stage of the company’s journey as they look to deliver its offering to a wider range of use cases and across new geographies."
— Heather Roxborough, senior partner of Health Tech